Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-047880
Filing Date
2014-02-12
Accepted
2014-02-12 15:01:52
Documents
2
Group Members
ANSBERT GADICKEJAMES PAUL SCOPAKURT WHEELERLUKE EVNINMICHAEL STEINMETZMPM ASSET MANAGEMENT II LLCMPM ASSET MANAGEMENT II, L.P.MPM ASSET MANAGEMENT INVESTORS 2000B LLCMPM BIOVENTURES GMBH & CO. PARALLEL-BETEILIGUNGS KGMPM BIOVENTURES II, L.P.MPM BIOVENTURE

Document Format Files

Seq Description Document Type Size
1 SC 13G d677590dsc13g.htm SC 13G 294207
2 EX-A d677590dex99a.htm EX-99.A 27327
  Complete submission text file 0001193125-14-047880.txt   323693
Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9640 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Subject) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87928 | Film No.: 14599670
SIC: 2834 Pharmaceutical Preparations

Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 6174259200
MPM BIOVENTURES II QP LP (Filed by) CIK: 0001264830 (see all company filings)

EIN.: 043523699 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G